Huntington National Bank’s GENZYME CORP GENZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$76 Hold
1
﹤0.01% 2688
2025
Q4
$76 Hold
1
﹤0.01% 2611
2025
Q3
$76 Hold
1
﹤0.01% 2699
2025
Q2
$76 Hold
1
﹤0.01% 2747
2025
Q1
$76 Hold
1
﹤0.01% 2778
2024
Q4
$76 Hold
1
﹤0.01% 2804
2024
Q3
$76 Hold
1
﹤0.01% 2799
2024
Q2
$76 Hold
1
﹤0.01% 2765
2024
Q1
$76 Hold
1
﹤0.01% 2590
2023
Q4
$76 Hold
1
﹤0.01% 2498
2023
Q3
$76 Hold
1
﹤0.01% 2470
2023
Q2
$76 Hold
1
﹤0.01% 2447
2023
Q1
$76 Hold
1
﹤0.01% 2288
2022
Q4
$76 Hold
1
﹤0.01% 2150
2022
Q3
$0 Hold
1
﹤0.01% 2879
2022
Q2
$0 Hold
1
﹤0.01% 2882
2022
Q1
$0 Hold
1
﹤0.01% 2808
2021
Q4
$0 Hold
1
﹤0.01% 2734
2021
Q3
$0 Hold
1
﹤0.01% 2459
2021
Q2
$0 Hold
1
﹤0.01% 2348
2021
Q1
$0 Hold
1
﹤0.01% 2238
2020
Q4
$0 Hold
1
﹤0.01% 2215
2020
Q3
$0 Hold
1
﹤0.01% 2161
2020
Q2
$0 Hold
1
﹤0.01% 2174
2020
Q1
$0 Hold
1
﹤0.01% 2268
2019
Q4
$0 Hold
1
﹤0.01% 2279
2019
Q3
$0 Hold
1
﹤0.01% 2185
2019
Q2
$0 Buy
+1
New ﹤0.01% 2219
2019
Q1
Sell
-1
Closed 2216
2018
Q4
$0 Hold
1
﹤0.01% 2271
2018
Q3
$0 Buy
+1
New ﹤0.01% 2258

Huntington National Bank's GENZ Position: Q1 2026 in Review

Huntington National Bank held its GENZYME CORP (GENZ) position steady in Q1 2026 at 1 share worth $76. The position accounts for ﹤0.01% of the portfolio, ranked #2688.

Huntington National Bank first reported a position in GENZ in Q3 2018 and has held it in 30 quarters since. 1 fund tracked by Wall St. Rank holds GENZ as of Q1 2026.

  • Huntington National Bank held 1 share of GENZYME CORP worth $76 as of Q1 2026.
  • Huntington National Bank left its GENZYME CORP share count unchanged in Q1 2026.
  • GENZYME CORP made up ﹤0.01% of Huntington National Bank's portfolio in Q1 2026, its #2688 holding.
  • Huntington National Bank first reported a position in GENZYME CORP in Q3 2018 and has held it in 30 quarters since.
  • 1 fund tracked by Wall St. Rank held GENZYME CORP as of Q1 2026.

Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.